These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12784540)

  • 1. [Formulation of St. John's wort extract. A medicinal obstacle course].
    Schmidt PC
    Pharm Unserer Zeit; 2003; 32(3):203-11. PubMed ID: 12784540
    [No Abstract]   [Full Text] [Related]  

  • 2. [Charge conformity and biopharmaceutic characterization. St. John's Wort extract preparations in comparison].
    Wurglics M; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2003; 32(3):236-41. PubMed ID: 12784544
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
    Rückert U; Likussar W; Michelitsch A
    Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining hyperforin and hypericin content in eight brands of St. John's wort.
    de los Reyes GC; Koda RT
    Am J Health Syst Pharm; 2002 Mar; 59(6):545-7. PubMed ID: 11908248
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of St. John's wort on free radical production.
    Hunt EJ; Lester CE; Lester EA; Tackett RL
    Life Sci; 2001 Jun; 69(2):181-90. PubMed ID: 11441908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
    Nahrstedt A; Butterweck V
    J Nat Prod; 2010 May; 73(5):1015-21. PubMed ID: 20408551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem).
    Murch SJ; Rupasinghe HP; Saxena PK
    Planta Med; 2002 Dec; 68(12):1108-12. PubMed ID: 12494339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Batch-to-batch reproducibility of St. John's wort preparations.
    Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilovecz M
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S152-6. PubMed ID: 11518067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of dynamic accumulation of secondary metabolites in three subspecies of Hypericum perforatum.
    Filippini R; Piovan A; Borsarini A; Caniato R
    Fitoterapia; 2010 Mar; 81(2):115-9. PubMed ID: 19686808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
    Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
    Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G; Schüle C; Baghai T; Kieser M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biorelevant dissolution testing of St John's wort products.
    Westerhoff K; Kaunzinger A; Wurglics M; Dressman J; Schubert-Zsilavecz M
    J Pharm Pharmacol; 2002 Dec; 54(12):1615-21. PubMed ID: 12542890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dangerous interaction of St. John's wort with chemotherapy?].
    Schmitt J
    Pharm Unserer Zeit; 2003; 32(1):8. PubMed ID: 12577753
    [No Abstract]   [Full Text] [Related]  

  • 18. Fast high-performance liquid chromatographic analysis of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts.
    Tolonen A; Hohtola A; Jalonen J
    Phytochem Anal; 2003; 14(5):306-9. PubMed ID: 14516003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
    Wang EJ; Barecki-Roach M; Johnson WW
    J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The production of hypericins and hyperforin by in vitro cultures of St. John's wort (Hypericum perforatum).
    Kirakosyan A; Sirvent TM; Gibson DM; Kaufman PB
    Biotechnol Appl Biochem; 2004 Feb; 39(Pt 1):71-81. PubMed ID: 14521510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.